Pathogenesis of non-alcoholic fatty liver disease mediated by YAP
Authors:
- 12 January 2018
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 12 (1) , 26-36
Abstract
This study aimed to investigate the mechanism of the interaction between Yes-associated protein (YAP) and transforming growth factor-β (TGF-β)/Smad signaling pathways in the development of non-alcoholic fatty liver disease (NAFLD).Keywords
Funding Information
- National Key Technology Support Program (2014BAI03B01)
- National Key Scientific Instrument and Equipment Development Project of China (2013YQ49085906)
This publication has 21 references indexed in Scilit:
- YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal FibrogenesisJournal of the American Society of Nephrology, 2016
- Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad ComplexesJournal of Molecular Biology, 2015
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐upHepatology, 2014
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiologyNature Communications, 2013
- Origin and function of myofibroblasts in kidney fibrosisNature Medicine, 2013
- Cytokeratin 18, a Marker of Cell Death, Is Increased in Children With Suspected Nonalcoholic Fatty Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008
- Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular ReactionGastroenterology, 2007
- Prevalence of and risk factors for fatty liver in a general population of Shanghai, ChinaJournal of Hepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Smad7 Inhibits Fibrotic Effect of TGF-β on Renal Tubular Epithelial Cells by Blocking Smad2 ActivationJournal of the American Society of Nephrology, 2002